Saturday, 23 May 2026 01:50 PM
Advertorial
A verification-first buyer's review of the 500 mg UthPeak™ NMNH capsule from ProHealth Longevity - covering Phase I clinical data, NAD+ pathway mechanism, ingredient-level evidence, dosing, pricing, the 100-day guarantee, and what reduced NMN buyers should verify before purchasing in 2026
CARPINTERIA, CA / ACCESS Newswire / May 23, 2026 / ADVERTORIAL - This article contains affiliate links and is sponsored content. A commission may be earned on qualifying purchases made through links in this content, at no additional cost to the reader. Affiliate relationships do not influence the evaluation of products or the editorial content herein. Disclosure is provided in accordance with FTC 16 CFR Part 255. The statements in this article have not been evaluated by the Food and Drug Administration. Products discussed are not intended to diagnose, treat, cure, or prevent any disease. Individual results vary. Consult a licensed healthcare professional before starting any new supplement.
Reviewed and Last Updated: 2026. This review reflects Phase I prepublication data from EffePharm (2025), verified label data from ProHealth (REV.05.25), and current competitive analysis. It will be updated as peer-reviewed data becomes available.
TL;DR - ProHealth Longevity Pure NMNH 500 mg Review (2026): ProHealth Pure NMNH delivers 500 mg of UthPeak™ per capsule - the only form of reduced NMN to complete a registered, double-blind, placebo-controlled Phase I human study (EffePharm prepublication data, 2025). One capsule daily matches the highest-dose arm studied. Ingredient-level data reported a threefold increase in NAD+ levels and changes in biological-age markers; findings apply to UthPeak™ NMNH and have not been independently confirmed for the finished ProHealth product. USA-manufactured, triple third-party tested, 100-day money-back guarantee. Read before buying.
ProHealth Longevity Pure NMNH 500 mg Review (2026): The Reduced NMN With Actual Human Trial Data - What Top Publications Are Getting Wrong
If you've been paying attention to the NAD+ booster and longevity supplement space in 2026, NMNH is the conversation that replaced the NMN-vs-NR debate. And for good reason: reduced NMN operates through a distinct enzymatic pathway that supports the body's NAD+ production. NAD+ is a coenzyme involved in cellular energy, mitochondrial function, and healthy aging processes at the cellular level. It completed the first registered Phase I human clinical trial in its category in 2025, and it's available right now from one of the longest-standing quality manufacturers in the industry.
Here's what makes this review different from what's currently ranking: as of this publication, several major health publications - including Fortune's top-ranked NMN guide - are still telling readers that NMNH "hasn't been studied to the same extent" and is "less proven." That assessment predates the UthPeak™ Phase I completion. It's out of date. And buyers making purchasing decisions based on it are working with the wrong information.
This review reflects the actual current state of the evidence. It covers what the Phase I data shows, where the caveats are, what the label confirms, what it costs, and the precise trade-offs a buyer in 2026 needs to understand before committing to a premium-priced ingredient in a rapidly evolving category.
View current ProHealth Pure NMNH 500 mg pricing and availability here
Official Website: prohealth.com/products/prohealth-pure-nmnh-500-mg-30-capsules-ph751
Key Takeaways at a Glance
What it is: 500 mg of UthPeak™ NMNH (reduced NMN) per capsule - a next-generation NAD+ booster designed to support cellular energy, mitochondrial function, and healthy aging through a distinct enzymatic pathway
Clinical backing: The first NMNH form with completed Phase I human trial data (prepublication, EffePharm, 2025) - 80 participants, 90 days, double-blind, placebo-controlled
Reported outcomes at 500 mg/day (EffePharm prepublication, 2025): Threefold plasma NAD+ increase, 35% energy improvement, 31% emotional wellness improvement, and biological-age marker changes equivalent to approximately five fewer years - ingredient-level findings, not independently confirmed for the finished product
Mechanism: Bypasses rate-limiting enzymatic steps that standard NMN and NR cannot, supporting more rapid and sustained NAD+ conversion according to preclinical research
Quality infrastructure: USA-manufactured, triple third-party tested, batch-specific Certificates of Analysis published publicly, 21 CFR Part 111 GMP-described facilities
Pricing: $119.95 one-time / $107.96 Subscribe & Save for 30-day supply at clinical dose
Risk reduction: 100-day money-back guarantee - one of the longest in the supplement category
Best for: Experienced NAD+ supplementers seeking the most evidence-backed reduced NMN ingredient available
Compliance note: Clinical data applies to the UthPeak™ ingredient and has not been independently confirmed for the finished ProHealth product; statements have not been evaluated by the FDA
Why 2026 Is the Inflection Point for NMNH - And Why Waiting Has a Cost
Three things are now true simultaneously that weren't true twelve months ago, and together they make 2026 the most informed moment in NMNH category history.
Human clinical data now exists. The UthPeak™ Phase I trial is completed, registered at ClinicalTrials.gov as NCT06889740, and its prepublication findings have been reported publicly by EffePharm. Buyers evaluating NMNH last year had only preclinical animal and cell data. Buyers evaluating it today have the first human trial data in the category - a material change in what's available to verify.
The NAD+ regulatory landscape just clarified. The FDA reversed its 2022 exclusion of NMN from supplement status in September 2025, stabilizing the broader NAD+ booster category. NMNH was never caught in that regulatory uncertainty. Buyers tracking regulatory risk in the longevity supplement space have a clearer purchasing environment than at any point since 2022.
Most published reviews still haven't caught up. Some of the highest-ranking content on NMNH still describes it as understudied or experimental, citing coverage written before the Phase I completion. Buyers relying on that content are making decisions with outdated information. This article closes that gap.
No countdown timers. No "limited stock" pressure. No fabricated urgency. The urgency here is informational - the data has moved, the category has moved, and most reviews haven't.
What Is NMNH? The Reduced Form of NMN That's Changing the NAD+ Category
NMNH - dihydronicotinamide mononucleotide - is the reduced form of NMN. One hydrogen atom separates it structurally from NMN, but that difference creates a meaningfully distinct biochemical pathway that has longevity researchers paying close attention.
Standard NMN and NR both depend on specific enzymes to complete their conversion into NAD+. Those enzymatic steps create bottlenecks - when the relevant enzymes are occupied or in short supply, conversion efficiency drops. NMNH sidesteps that limitation. According to the company and published preclinical research, NMNH converts first into NADH through adenosine kinase (AK) - an enzyme that operates on a separate pathway - then into NAD+. The result is a conversion route that doesn't compete for the same enzymatic resources as NMN or NR.
These statements describe structure/function research related to cellular metabolism and have not been evaluated by the FDA.
The practical implication for anyone already running an NMN or NR protocol: NMNH doesn't displace your existing stack. Per the brand, it can be layered in alongside NMN or NR as a complementary mechanism rather than a direct substitute. That's not a marketing position - it reflects the fact that the enzymatic pathways genuinely don't compete.
A 2020 preclinical study found NMNH demonstrated greater NAD+ elevation than NMN in certain cellular and animal models. A separate study showed a fivefold NAD+ increase in HepG2 cells specifically. Those preclinical findings were the basis for advancing to human trials - and the UthPeak™ Phase I study is where the human data begins.
NMNH vs. NMN in 2026: The Honest Comparison Buyers Are Searching For
This is the most-searched comparison in the NAD+ precursor category right now, and the internet's current answer is mostly hedged or manufacturer-sourced. Here's the accurate version.
NMN has a deeper peer-reviewed human evidence base. Multiple published trials confirm that NMN raises NAD+ levels in humans and is well-tolerated across a range of doses. That track record doesn't yet exist for NMNH at the same depth - but NMNH's human data is now building, and UthPeak™ is leading that development.
NMNH's key mechanistic advantage over NMN is the AK enzyme pathway. Preclinical research found NMNH demonstrated greater NAD+ elevation than NMN in certain cellular and animal models. According to EffePharm's prepublication Phase I data, a single dose of NMNH supported NAD+ elevation that remained measurable for more than 20 hours - a duration that standard NMN precursors don't consistently achieve in the published record. This extended NAD+ support window is one of the distinguishing features cited in UthPeak™ research materials.
The honest answer to "is NMNH better than NMN?" is: it works differently, the Phase I human data is the strongest in its category, and its distinct mechanism makes it a genuine addition to - rather than a replacement for - an NMN protocol. For an experienced NAD+ supplementer looking for a next step with ingredient-level human trial data behind it, NMNH is currently the best-evidenced option in its category. For a first-time NAD+ buyer, NMN's longer peer-reviewed human record is still the more conventional starting point.
The UthPeak™ Phase I Clinical Trial: A Complete, Accurate Breakdown
This is the section of any NMNH review that deserves precise reading. The clinical picture is genuinely compelling. It also deserves the accurate context that most coverage of this ingredient skips.
EffePharm - the manufacturer of UthPeak™ - sponsored and completed a Phase I randomized, double-blind, placebo-controlled human clinical study registered at ClinicalTrials.gov as NCT06889740. The study is described by EffePharm as the world's first and largest completed human clinical trial on NMNH. It enrolled 80 healthy adult participants across four groups: placebo, 125 mg daily, 250 mg daily, and 500 mg daily NMNH. Participants supplemented for 90 consecutive days. Outcomes measured included plasma NAD+ levels, biological-age markers (using an epigenetic evaluation method developed by UCLA aging researchers), a six-minute walk test, and quality-of-life assessments including energy and emotional wellness scores.
According to prepublication data reported by EffePharm (2025):
The 500 mg daily group experienced approximately a threefold increase in plasma NAD+ levels over the 90-day period
Participants in the NMNH groups reported a 35% increase in energy levels and a 31% improvement in emotional wellness scores (EffePharm prepublication data, 2025 - individual results vary)
Biological-age markers in the NMNH group showed changes consistent with approximately five fewer biological years at study end (EffePharm prepublication data, 2025 - should not be interpreted as guaranteed age reversal)
No significant adverse effects were reported; safety was confirmed across blood chemistry, lipid profile, liver function, renal function, and urinalysis measurements
Self-affirmed GRAS (Generally Recognized As Safe) status has been obtained by EffePharm for UthPeak™ NMNH
The precise framing every buyer needs: these are ingredient-level findings from prepublication Phase I data on UthPeak™ NMNH. They have not completed peer review in a major scientific journal. They have not been independently confirmed for the finished ProHealth product formulation. They should not be interpreted as a guarantee of specific outcomes for individual buyers.
With that framing accurately in place: a registered, completed, 80-participant, 90-day double-blind RCT is a substantially higher clinical bar than anything else in the NMNH category currently clears. The data is real. The caveats are equally real. Both deserve to be in the same sentence, and this review puts them there.
ProHealth's product page references seven additional published studies supporting NMNH and NAD+ precursor research, including peer-reviewed human NMN trials published in Endocrine Journal (Irie et al., 2020), Scientific Reports (Fukamizu et al., 2022), Frontiers in Nutrition (Okabe et al., 2022), and Nature Communications (Trammell et al., 2016). These are not studies on the finished ProHealth product - they are published peer-reviewed research that forms the broader scientific context for NMNH and NAD+ precursor supplementation. Their inclusion on the product page reflects a transparency standard most supplement brands in this category don't attempt.
What the Supplement Facts Label Confirms
The Supplement Facts label for Pure NMNH 500 mg (SKU PH751, REV.05.25) shows:
UthPeak™ ß-Nicotinamide Dihydronicotinamide Mononucleotide (NMNH): 500 mg per capsule
Serving size: 1 capsule
Servings per container: 30
Other ingredients: Cellulose (capsule), rice flour, silica
Suggested daily use: Take one (1) capsule per day, or as directed by your healthcare professional
One capsule delivers the full 500 mg dose - the same daily amount used in the highest-dose arm of the UthPeak™ Phase I study, which reported the strongest NAD+ outcomes across all study groups. The capsule shell is cellulose, a plant-derived material compatible with vegan use. A 30-capsule bottle is a 30-day supply at the suggested serving.
UthPeak™ is a registered trademark of EffePharm Ltd. The crystalline form used in this product is the same patent-pending form that underwent Phase I clinical evaluation - not a generic or unbranded NMNH equivalent.
ProHealth Longevity: 37 Years of Manufacturing and a Transparency Standard Most Supplement Brands Won't Match
ProHealth Longevity was founded in 1988 by Rich Carson while he was researching supplements to address his own diagnosis of ME/CFS (myalgic encephalomyelitis/chronic fatigue syndrome). That founding context shapes the company's stated culture - "Commerce with Compassion" - and a reported nearly $5 million donated to medical research and patient advocacy since inception.
What matters more to a buyer doing due diligence is the manufacturing and testing infrastructure behind the product. Every batch of Pure NMNH is produced in the USA in facilities the brand describes as FDA-regulated and GMP-certified under 21 CFR Part 111. Each batch undergoes three independent rounds of third-party laboratory testing for potency, purity, and safety. ProHealth publishes its Certificates of Analysis publicly - the COA for the lot reviewed here (lot A25G012) is linked directly from the product page at prohealth.com/products/prohealth-pure-nmnh-500-mg-30-capsules-ph751.
That last point deserves emphasis. Most supplement brands don't publish batch-specific COAs. Publishing them doesn't just signal quality - it creates verifiable accountability. If the COA says 500 mg of UthPeak™ NMNH per capsule, the batch has to confirm it. For a buyer who wants to independently verify ingredient identity and potency before purchasing, ProHealth makes that verification possible in a way that most competitors' processes don't. The same triple-testing and COA transparency standard applies across ProHealth's broader lineup - including its synbiotic peptide formulation. Prior coverage of ProHealth's BPC-157 Ultra Probiotic examined how that quality infrastructure holds up across a more complex multi-ingredient formula.
The company reports a long-standing A+ rating from the Better Business Bureau. Ratings reflect brand-reported customer data; individual experiences and results vary.
What the Available Research and Customer Reviews Suggest
On the research side: preclinical studies found NMNH demonstrated greater NAD+ elevation than NMN in certain cellular and animal models. The UthPeak™ Phase I study (prepublication, EffePharm, 2025) reported measurable changes in plasma NAD+ levels, energy-related outcomes, and biological-age markers at the 500 mg daily dose over 90 days. Ingredient-level prepublication data reported changes in biological-age markers in healthy adults consistent with approximately five fewer biological years at study end. This should not be interpreted as guaranteed age reversal or as a confirmed outcome for the finished ProHealth product formulation.
On the customer side: Pure NMNH 500 mg carries a 4.8-out-of-5 rating based on verified reviews on the ProHealth website and iHerb at the time of this review. Ratings reflect brand-reported and third-party platform customer data; individual experiences and results vary. Customer commentary centers consistently on energy-level changes and improved stamina, with some buyers reporting noticeable differences within the first week at 500 mg. One reviewer described transitioning from daily NMN to alternating NMN and NMNH on separate days, noting a subjectively more effective response. Another upgraded from the 125 mg option after minimal response, then noticed a change on the first day at the full 500 mg dose.
Customer testimonials reflect individual experiences. Results are not typical and are not clinical proof of efficacy. Individual responses to dietary supplements vary based on age, health status, baseline NAD+ levels, lifestyle, and other factors.
The pattern in customer feedback aligns directionally with the clinical mechanism. Energy-related outcomes and quality-of-life measures were among the endpoints evaluated in the Phase I study, and the dose-dependent response pattern in customer reports (stronger response at higher doses) is consistent with the Phase I study's dose-stratified design. Anecdotal reports are not a substitute for controlled research - but alignment between controlled findings and real-world reports is meaningful context for a buyer evaluating a premium product.
Check the current ProHealth Pure NMNH offer and availability here
How ProHealth Pure NMNH Compares to Other NMNH Products in 2026
The NMNH supplement category has grown rapidly. Several brands now offer NMNH or "reduced NMN" products. Here's where the differentiation actually sits based on available 2026 data.
GenuinePurity NMNH uses a liposomal delivery format and is manufactured by Leading Edge Health. Like ProHealth's product, it uses the UthPeak™ ingredient - meaning the core active compound is the same. The differentiation is in delivery technology, capsule count, pricing, and brand transparency infrastructure. GenuinePurity's liposomal format may offer bioavailability advantages per delivery-format research, though no comparative finished-product trial exists between the two. ProHealth's 37-year track record, published batch COAs, and triple third-party testing give it a distinct transparency edge.
Toniiq NMNH also uses the UthPeak™ ingredient and is available at a lower price point, though without the published COA transparency and triple-testing protocol that ProHealth maintains.
ProHealth Essentials NMNH - the brand's own lower-cost line - uses Nexergy+™ NMNH, an amorphous form positioned for enhanced bioavailability per milligram at a lower price point. It does not carry the Phase I RCT data that the UthPeak™ ingredient holds. ProHealth also offers an Essentials NMN 500 line featuring Nexergy™ NMN - a separate, budget-accessible standard NMN formulation for buyers who want the NAD+ precursor molecule without the premium ingredient pricing. Earlier analysis of the ProHealth Essentials NMN 500 and Nexergy™ formulation covers what buyers in that price tier should verify before purchasing.
For buyers whose primary criterion is ingredient-level Phase I human clinical data, UthPeak™ is the current answer, and ProHealth and GenuinePurity are the two main access points. For buyers prioritizing price-per-dose, Toniiq or ProHealth Essentials are the more cost-efficient paths. The right choice depends on what a specific buyer needs to verify before they're comfortable committing to a purchase at this price point.
What Does ProHealth Pure NMNH Cost?
ProHealth Longevity offers Pure NMNH in three strength options, each priced based on potency and capsule count. All versions are available as a one-time purchase or through a Subscribe & Save program that reduces the per-order cost by approximately 10%. Free U.S. shipping applies to qualifying orders over $30. Prices below reflect what the brand lists at time of publication - always verify current pricing at the official website before ordering, as prices are subject to change.
Pure NMNH 125 mg - 60 Capsules
One-time purchase: $59.95 | Subscribe & Save: $53.96
60 capsules per bottle at 125 mg UthPeak™ NMNH per capsule. According to the company, this option suits individuals beginning NMNH supplementation or those who prefer a lower daily dose with an extended supply. At one capsule per day, this is a 60-day supply at roughly $1.00 per day.
Pure NMNH 250 mg - 30 Capsules
One-time purchase: $59.95 | Subscribe & Save: $53.96
30 capsules per bottle at 250 mg UthPeak™ NMNH per capsule. The mid-range potency option. At one capsule daily, this is a 30-day supply. Note: this SKU delivers 250 mg per capsule - half the per-capsule amount of the 500 mg product reviewed here, at the same bottle price.
Pure NMNH 500 mg - 30 Capsules
One-time purchase: $119.95 | Subscribe & Save: $107.96
30 capsules per bottle at 500 mg UthPeak™ NMNH per capsule. One capsule daily delivers the full 500 mg dose studied in the UthPeak™ Phase I clinical trial (prepublication data, EffePharm, 2025). According to the company, this version is intended for buyers seeking the highest-potency option in the Pure NMNH lineup. At one capsule daily, this is a 30-day supply at $4.00 per day (one-time) or $3.60 per day on Subscribe & Save.
For buyers who want a longer supply at once, ProHealth also offers the 500 mg formula in a 120-capsule bottle - a 120-day supply at one capsule daily. Pricing for that size was not confirmed at time of publication; verify directly at prohealth.com/products/prohealth-pure-nmnh-500-mg-30-capsules-ph751.
Additional purchase benefits the brand lists: Subscribe & Save discount of approximately 10%, free U.S. shipping on orders over $30, 100-day money-back guarantee, flexible one-time or recurring purchase options, and multiple potency levels for individualized supplementation.
Refund Policy, Guarantee, and How to Reach ProHealth
ProHealth Longevity backs Pure NMNH with a 100-day, 100% satisfaction guarantee. Return the unused portion within 100 days and you receive a full refund of the product cost. Shipping charges are not refunded. For multi-pack orders, the return is accepted only if no more than one bottle has been opened, with all remaining bottles returned in their original sealed condition.
At one capsule daily, 100 days covers more than three months of use before the guarantee window closes - substantive time to evaluate your response before the guarantee expires. That window is meaningfully longer than the 30- or 60-day policies standard in the supplement category.
Customer service is available Monday through Friday, 8 AM to 5 PM Pacific Time.
Email: [email protected] | Toll-free: (800) 366-6056 | US direct: (805) 564-3064 | International: 001.805.564.3064 | Pharmaceutical support: (800) 366-5924 | Fax: (805) 684-6199
Returns: ProHealth, Inc., 1025 Cindy Lane, Carpinteria, CA 93013 USA
ProHealth Pure NMNH Pros and Cons
Pros:
The first NMNH ingredient with completed Phase I human clinical trial data (prepublication, EffePharm, 2025)
500 mg per capsule matches the highest-dose arm in the Phase I study - one capsule daily delivers the clinical dose
Distinct AK enzyme pathway may support more rapid and sustained NAD+ elevation than standard NMN or NR according to preclinical research
Reported 20+ hour NAD+ support window per ingredient-level prepublication data - longer than typical NMN duration
USA-manufactured in facilities the brand describes as GMP-certified under 21 CFR Part 111
Triple third-party laboratory testing on every batch with publicly accessible Certificates of Analysis
Self-affirmed GRAS status on the UthPeak™ ingredient per EffePharm safety documentation
100-day money-back guarantee - among the longest in the supplement category
37-year manufacturing track record with brand-reported A+ BBB rating
Stackable with existing NMN or NR protocols due to distinct enzymatic pathway
Vegan-compatible capsule (cellulose) with minimal other ingredients (rice flour, silica)
No artificial fillers, no proprietary blends - full ingredient transparency
Cons:
Phase I clinical data is prepublication - peer review has not yet completed
Clinical findings apply to the UthPeak™ ingredient, not independently verified for the finished product
Premium pricing relative to standard NMN supplements ($119.95 for 30-day clinical-dose supply)
Less suitable as a first-time NAD+ supplement - NMN has a deeper peer-reviewed human evidence base for that buyer
Only sold direct from ProHealth and a limited number of authorized retailers (Amazon third-party sellers are not authorized and not covered by the guarantee)
Individual response varies - no specific outcome can be guaranteed for any individual
What Honest Evaluation Requires Acknowledging
What supports this product: UthPeak™ is, based on currently available trial data, one of the first NMNH ingredients with a completed, registered, double-blind Phase I human study (prepublication, EffePharm, 2025) - a level of ingredient evidence that no other NMNH product in the 2026 market can match from publicly available trial data. ProHealth's 37-year manufacturing history, published batch COAs, triple third-party testing, USA GMP-described manufacturing, and Self-GRAS certified ingredient together represent an above-average transparency stack for this category. The 100-day return window is one of the most generous in the supplement space and reduces first-purchase risk meaningfully.
What complicates the purchase decision: The Phase I data is prepublication - every specific outcome figure should be evaluated with the understanding that independent peer review has not yet been completed. Pricing was not confirmed from the live product page at time of writing - always check prohealth.com before purchasing. Individual response to NAD+ precursors varies substantially; no specific outcome is guaranteed.
View current ProHealth Pure NMNH details and pricing here
Is ProHealth Pure NMNH Legitimate? Four Factors That Answer the Question
Legitimacy in the supplement space comes down to four verifiable factors: ingredient clinical backing, manufacturing transparency, third-party testing, and company history. ProHealth Pure NMNH clears all four.
The UthPeak™ ingredient is backed by a completed, registered Phase I human trial (prepublication data, EffePharm, 2025). Manufacturing is USA-based in facilities the brand describes as GMP-certified under 21 CFR Part 111. Testing is triple-layer with publicly accessible batch-specific COAs. ProHealth has operated continuously since 1988 with a brand-reported A+ BBB rating.
Legitimate does not mean guaranteed to produce any specific result. NAD+ precursor response is individual, dose-dependent, and shaped by factors unique to each person. The 100-day guarantee exists precisely because that variability is real. If your response doesn't match your expectations within 100 days, the guarantee is your exit. Use it if you need it.
Who Should Consider ProHealth Pure NMNH - and Who Should Wait
Strong candidate: Someone who has already established a baseline response with NMN or NR and wants to explore the NMNH mechanism - the distinct AK enzyme pathway, the extended NAD+ support window reported in preclinical data, and the potential for stacking with an existing NAD+ protocol. If "does the specific ingredient have Phase I human trial data?" is a real criterion in your purchasing decisions, UthPeak™ in ProHealth's formulation is the current answer in the NMNH category.
Less obvious fit: Someone brand-new to NAD+ supplementation who hasn't yet established a baseline experience with NMN or NR. NMN's deeper peer-reviewed human record makes it the more conventional starting point for that buyer. ProHealth makes both - the NMN Pro line and the Pure NMNH line are clearly differentiated on the brand's site, and starting with the molecule that has the longest human evidence track record is the more sensible first protocol for most people.
Worth noting for stacking: Some buyers in the longevity community use NMNH and NMN on alternating days rather than replacing one with the other. The distinct enzymatic pathways make this a theoretically complementary approach, and it's a pattern that appears in customer reviews of both products. As with any multi-supplement protocol, consulting a healthcare professional before combining NAD+ precursors is the appropriate step.
ProHealth Pure NMNH - Frequently Asked Questions
What is NMNH and how is it different from NMN?
NMNH (dihydronicotinamide mononucleotide) is the reduced form of NMN - one hydrogen atom added to the structure, but a meaningfully distinct biochemical pathway as a result. NMN and NR both require specific enzymes to convert into NAD+, and those enzymatic steps can become bottlenecks. According to the company and published preclinical research, NMNH converts into NADH first via adenosine kinase (AK) - a separate enzymatic route that doesn't compete for the same conversion resources. A 2020 preclinical study found NMNH demonstrated greater NAD+ elevation than NMN in certain cellular and animal models; a separate study showed a fivefold increase in HepG2 cells specifically. The UthPeak™ Phase I human study (prepublication data, EffePharm, 2025) reported changes in plasma NAD+ levels at the 500 mg daily dose over 90 days. Those findings are ingredient-level data on UthPeak™ NMNH and have not been independently confirmed for the finished ProHealth product. Per the brand, NMNH can also be stacked with NMN or NR because the mechanisms operate through distinct enzymatic pathways.
Is NMNH better than NMN for raising NAD+ levels?
In preclinical research, NMNH demonstrated greater NAD+ elevation than NMN in certain cellular and animal models. The UthPeak™ Phase I human study (prepublication, EffePharm, 2025) reported approximately a threefold increase in plasma NAD+ at 500 mg daily over 90 days. NMN, by contrast, has a substantially deeper peer-reviewed human evidence base - multiple published trials confirm its NAD+-raising effects. The accurate framing is that NMNH operates through a different mechanism that may support more rapid or more sustained NAD+ conversion according to preclinical research, but NMN's human evidence base is more extensively peer-reviewed. For experienced NMN users looking for a next step, NMNH backed by UthPeak™ Phase I data is the most evidence-backed option in its category. For someone new to NAD+ supplementation, NMN's depth of peer-reviewed research makes it the more conventional starting point.
How much NMNH is in each capsule, and does it match the clinical dose?
The Supplement Facts label for the 500 mg SKU (PH751, REV.05.25) confirms 500 mg of UthPeak™ NMNH per capsule, with a suggested daily use of one capsule per day. One capsule delivers the full 500 mg dose - the same daily amount used in the highest-dose arm of the UthPeak™ Phase I clinical trial (prepublication data, EffePharm, 2025), which reported the strongest NAD+ outcomes across all study groups. A 30-capsule bottle is a 30-day supply at the suggested serving. ProHealth also offers the same formulation in a 120-capsule bottle for buyers who want a longer supply at once.
What does "changes in biological-age markers" actually mean?
The Phase I study used an epigenetic measurement method associated with UCLA aging research to assess biological age. Prepublication data from EffePharm reported changes in biological-age markers in the NMNH group consistent with approximately five fewer biological years at study end. Biological age reflects how cells and tissues are functioning relative to chronological age - it's not the same as reversing calendar years. This finding is ingredient-level prepublication data on UthPeak™ NMNH; it has not completed peer review and should not be interpreted as guaranteed age reversal or as a confirmed outcome for the finished ProHealth product. It's reported here with that exact framing because accurate context serves a buyer far better than promotional shorthand.
Is UthPeak™ NMNH Self-GRAS certified?
Yes. According to EffePharm, UthPeak™ NMNH has achieved self-affirmed GRAS (Generally Recognized As Safe) status, confirmed through expert evaluations and toxicological testing. EffePharm also reports that comprehensive toxicology testing conducted in 2023 found no acute oral toxicity at high doses, and the Phase I clinical trial confirmed no significant adverse effects on clinical laboratory measurements including blood chemistry, lipid profile, liver function, renal function, and urinalysis. Self-affirmed GRAS is an industry-recognized safety designation for dietary supplement ingredients, not an FDA approval - buyers should understand the distinction and consult a healthcare professional with any safety questions specific to their individual health situation.
Can NMNH be taken alongside NMN or NR?
According to the company, yes. Because NMNH uses a distinct enzymatic pathway from NMN and NR, the brand states it doesn't compete for the same conversion machinery - meaning the compounds may work complementarily rather than redundantly. Some customers report alternating NMNH and NMN on separate days as part of a broader NAD+ protocol. This approach appears in customer reviews across multiple platforms and aligns with the mechanistic distinction between the two molecules. As with any combination of supplements that influence cellular energy pathways, consulting a healthcare professional before stacking is the appropriate step - particularly for anyone with pre-existing health conditions or who takes prescription medications.
Does ProHealth publish third-party lab results?
Yes. According to the brand, ProHealth publishes Certificates of Analysis for its products, with the COA for the lot reviewed here (lot A25G012) linked directly from the product page. The company describes a triple-testing protocol: three independent rounds of third-party laboratory testing for potency, purity, and safety on every batch. Publishing batch-specific COAs publicly is a transparency standard that most supplement brands in this category don't follow. For buyers who want to independently verify ingredient identity and potency before purchasing, ProHealth's approach makes that verification accessible. The COA is available at the official product page.
What is the return and refund policy?
ProHealth Longevity offers a 100-day, 100% satisfaction money-back guarantee on supplement products. Returning the unused portion within 100 days qualifies for a full refund of the product cost. Shipping charges are not refunded. For multi-pack orders, the policy requires that no more than one bottle has been opened and all remaining bottles are returned in original sealed condition. At one capsule daily, 100 days is more than three full months of use - a genuinely substantive evaluation window that meaningfully reduces the financial risk of a first purchase compared to the 30- or 60-day policies common in this category.
Is the capsule vegan-friendly?
The capsule shell is listed on the label as cellulose - a plant-derived material generally compatible with vegan use. Other listed ingredients are rice flour and silica, both plant-origin. The label doesn't carry an explicit vegan certification. Buyers with specific dietary requirements or allergen concerns should contact ProHealth directly at [email protected] or (800) 366-6056 to confirm current manufacturing practices before purchasing.
Is NMNH legal to sell as a dietary supplement in the United States in 2026?
Yes. NMNH has not been subject to the regulatory uncertainty that briefly affected NMN in the U.S. market. The FDA reversed its 2022 exclusion of NMN from supplement status in September 2025, which stabilized the broader NAD+ precursor category. NMNH was never caught in that regulatory dispute - it is legally sold as a dietary supplement under DSHEA, and ProHealth's product is manufactured in USA facilities the brand describes as GMP-certified under 21 CFR Part 111. Buyers who tracked the NMN regulatory situation and paused purchases during 2022-2025 uncertainty can note that NMNH's regulatory status has been clear throughout that period. As with any supplement, the FDA has not evaluated NMNH for safety or efficacy as a drug, and the product is not intended to diagnose, treat, cure, or prevent any disease.
What cautions apply and who should not take this supplement?
Per the label, Pure NMNH is formulated for use by healthy adults only and is not intended for use by children. The label directs individuals who are pregnant or nursing, under the age of 18, or currently undergoing medical treatment to consult a physician before use. Anyone taking prescription medications - particularly those that affect cellular energy pathways or mitochondrial function - should review any new supplement addition with a healthcare provider. Do not exceed the suggested use. Keep out of reach of children. Store in a cool, dry place after opening.
Where is ProHealth located and how do I contact customer service?
ProHealth, Inc. is headquartered at 1025 Cindy Lane, Carpinteria, CA 93013, USA. Customer service is available Monday through Friday, 8 AM to 5 PM Pacific Time. Contact: email [email protected]; toll-free (800) 366-6056; US direct (805) 564-3064; international 001.805.564.3064; pharmaceutical support (800) 366-5924; fax (805) 684-6199 (international: 001.805.684-6199). Returns should be sent to the Carpinteria address above with the original invoice or packing slip included where available.
How does ProHealth Pure NMNH compare to GenuinePurity and Toniiq NMNH in 2026?
All three products use the UthPeak™ NMNH ingredient, meaning the core active compound is sourced from the same manufacturer (EffePharm). The differentiation between them is in delivery format, pricing, brand transparency, and manufacturing track record. GenuinePurity uses a liposomal delivery format that may offer bioavailability advantages per delivery-format research, though no comparative clinical data exists between the finished products. Toniiq offers a lower price point but without ProHealth's published COA program and triple-testing protocol. ProHealth's advantage is brand longevity (37 years), published batch-specific COAs, triple third-party testing, and the 100-day guarantee - the strongest transparency infrastructure among the three. The right choice depends on whether a buyer prioritizes delivery-format innovation (GenuinePurity), price-per-dose (Toniiq), or brand transparency and quality assurance depth (ProHealth).
How long does NMNH take to work? When should I expect to feel a difference?
Individual response varies substantially based on baseline NAD+ levels, age, lifestyle, and other factors. According to customer reviews on the ProHealth website and iHerb, some buyers report noticing changes in energy levels within the first week at 500 mg daily, while others describe a more gradual onset over two to four weeks. The UthPeak™ Phase I clinical study (prepublication, EffePharm, 2025) measured outcomes over 90 consecutive days, which reflects the type of timeframe controlled research uses to capture sustained effects rather than short-term variations. If you're evaluating personal response, giving the product at least 30 to 60 days at the suggested serving is the more accurate window - and the 100-day money-back guarantee covers that evaluation period in full. Individual results vary; no specific outcome is guaranteed for any individual.
When is the best time of day to take NMNH for maximum effect?
The product label does not specify a particular time of day. According to user discussions across longevity research forums and customer reviews, the most common protocols involve taking NMNH in the morning with or without food, since the reported energy-related effects align with daytime activity windows. Some buyers in stacking protocols take NMNH and NMN at different times - for example, NMNH in the morning and NMN at midday - to support sustained NAD+ levels across the day. The Phase I clinical study did not isolate timing-of-day as a variable, so there is no clinical recommendation on optimal timing. Consulting a healthcare professional for personalized guidance, particularly if you take medications that affect cellular energy metabolism, is the appropriate next step. Do not exceed the suggested daily use of one capsule.
What are the potential side effects of NMNH and is it safe?
According to EffePharm's prepublication Phase I clinical trial data on UthPeak™ NMNH, the 90-day study reported no significant adverse effects on clinical laboratory measurements including blood chemistry, lipid profile, liver function, renal function, and urinalysis. Comprehensive toxicology testing conducted in 2023 (per EffePharm) found no acute oral toxicity at high doses, and the UthPeak™ ingredient has achieved self-affirmed GRAS status. That said, self-affirmed GRAS is an industry safety designation, not an FDA approval - and individual responses to any supplement can vary. Per the product label, Pure NMNH is formulated for healthy adults only and is not intended for children. Individuals who are pregnant or nursing, under 18, or undergoing medical treatment should consult a physician before use. Anyone taking prescription medications - particularly those affecting cellular energy or mitochondrial pathways - should review supplement additions with a healthcare provider. The product is not intended to diagnose, treat, cure, or prevent any disease.
What are the main NMNH benefits compared to regular NMN supplements?
The most-cited NMNH benefits versus standard NMN, based on currently available preclinical and prepublication clinical research, center on three areas. First, mechanism: NMNH bypasses rate-limiting enzymatic steps that NMN and NR both require, potentially supporting more rapid NAD+ conversion according to preclinical research. Second, duration: ingredient-level prepublication data from EffePharm reports NMNH may support extended NAD+ elevation, with single-dose effects measurable for more than 20 hours - longer than the typical duration documented for standard NMN. Third, magnitude: preclinical research found NMNH demonstrated greater NAD+ elevation than NMN in certain cellular and animal models, and the UthPeak™ Phase I human study reported approximately threefold NAD+ increases at 500 mg daily. These findings apply to the UthPeak™ ingredient and have not been independently confirmed for any finished product. NMN remains the more extensively peer-reviewed compound in humans; NMNH is the newer compound with the most recent clinical evidence in its specific category. Individual results vary; statements have not been evaluated by the FDA; products are not intended to diagnose, treat, cure, or prevent any disease.
See the current ProHealth Pure NMNH product page and up-to-date pricing here
The Bottom Line: Is ProHealth Pure NMNH Worth Buying in 2026?
For the right buyer, yes - and the right buyer is specific.
If you're an experienced NAD+ supplementer who has already established a baseline response with NMN or NR, who tracks ingredient-level clinical data when making purchasing decisions, and who values manufacturing transparency over the lowest available price, ProHealth Longevity's Pure NMNH 500 mg is currently the most evidence-backed reduced NMN product on the market. The UthPeak™ ingredient is the only NMNH form with completed Phase I human trial data (prepublication, EffePharm, 2025). The 500 mg per capsule matches the clinical dose. The triple-testing and published COA infrastructure is genuinely above category standard. The 100-day guarantee gives you a real evaluation window. That combination is hard to find elsewhere.
If you're new to NAD+ supplementation, this is probably not your first product. Start with NMN - its peer-reviewed human evidence base is deeper, its price point is lower, and you'll learn how your body responds to NAD+ precursors before committing to a premium ingredient. ProHealth makes both lines; you can move into Pure NMNH later if it makes sense for your protocol.
Either way, the decision should be based on accurate information - not the dated assessments that several major publications are still running. The science has moved. The data is here. Now you have it.
Email: [email protected]
Toll Free: (800) 366-6056
USA: (805) 564-3064
INT: 001.805.564.3064
USA Fax: (805) 684-6199
INT Fax: 001.805.684-6199
Pharmaceuticals Customer Support: (800)366-5924
Product Return Address: ProHealth, Inc. 1025 Cindy Lane Carpinteria, CA 93013 USA
View the official ProHealth Pure NMNH product page and current pricing here
FDA Disclaimer: The statements in this article have not been evaluated by the Food and Drug Administration. Products discussed are not intended to diagnose, treat, cure, or prevent any disease. Information provided is for general informational purposes and does not constitute medical advice. Readers experiencing symptoms or considering changes to health regimens should consult a licensed healthcare professional. Individual results vary.
FTC Affiliate Disclosure: This article contains affiliate links. A commission may be earned on qualifying purchases made through links in this content, at no additional cost to the reader. Affiliate relationships do not influence editorial content or the evaluation of products. Disclosure is provided in accordance with FTC 16 CFR Part 255.
Results Variability Disclaimer: Individual responses to dietary supplements vary based on age, health status, baseline nutrient levels, lifestyle, and other factors. Clinical outcomes referenced reflect ingredient-level results from a controlled Phase I study environment (prepublication data, EffePharm, 2025) and have not been independently confirmed for the finished ProHealth product. No guarantee of identical results is expressed or implied. Testimonials and customer reviews reflect individual experiences and are not representative of typical results.
Medical Advice Disclaimer: Nothing in this article constitutes medical advice, diagnosis, or a recommendation to use any specific product for any medical condition. Readers with health concerns, pre-existing medical conditions, or who take prescription medications should consult a licensed healthcare professional before adding any new supplement to their regimen.
Pricing and Availability Disclaimer: Product pricing reflects brand-listed amounts at time of publication and is subject to change without notice. Readers should verify current pricing, bundle options, and availability directly at the official website before purchasing. Official Website: prohealth.com/products/prohealth-pure-nmnh-500-mg-30-capsules-ph751.
Publisher Independence Disclaimer: This article reflects independent analysis of publicly available brand materials, ingredient research, and available clinical data. The publisher is not employed by, owned by, or affiliated with ProHealth, Inc. or EffePharm Ltd. Editorial conclusions are the publisher's own.
Clinical Data Disclaimer: Clinical data referenced for UthPeak™ NMNH reflects prepublication Phase I findings (EffePharm, 2025) that have not yet completed peer review. Preclinical data referenced reflects published animal and cellular studies. All clinical and preclinical data cited applies to the UthPeak™ ingredient, not to the finished ProHealth product formulation. Buyers should evaluate all claims with appropriate consideration for study stage, funding source, sample size, and peer-review status.
Platform and Retailer Disclaimer: This article is distributed through press release distribution platforms for informational purposes. ProHealth does not authorize third-party resellers on Amazon; purchases through unauthorized third-party Amazon sellers are not covered by ProHealth's 100-day satisfaction guarantee. The guarantee applies to purchases made directly through ProHealth.com or the authorized ProHealth Amazon storefront. Always purchase from the official brand source to ensure authenticity, quality assurance, and return eligibility.
SOURCE: ProHealth